Table 1 Dose-volume endpoint evaluation
From: Knowledge-based IMRT planning for individual liver cancer patients using a novel specific model
Structures | Acceptable criteria |
|---|---|
PTV | V95% > 95% |
|  | D98% > 47.50 Gy |
|  | D2% < 55.02 Gy |
Normal liver | Dmean < 23 Gy |
V30Gy < 28% | |
V40Gy < 24% | |
Spinal cord | Dmax < 40 Gy |
Right kidney | Dmean < 18 Gy |
V5Gy < 70% | |
V10Gy < 55% | |
V15Gy < 35% |